Drug Profile
PAMBAEEG
Latest Information Update: 24 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antivirals
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 20 Oct 1999 New profile
- 20 Oct 1999 Preclinical development for Influenza virus infections in Ukraine (Unknown route)